Literature DB >> 29453497

Bone mineralization and vascularization in bisphosphonate-related osteonecrosis of the jaw: an experimental study in the rat.

Jean-Daniel Kün-Darbois1,2, Hélène Libouban1, Guillaume Mabilleau1,3, Florence Pascaretti-Grizon1, Daniel Chappard4,5.   

Abstract

OBJECTIVES: Pathogenesis of bisphosphonate-related osteonecrosis of the jaws (BRONJ) is not fully explained. An antiangiogenic effect of bisphosphonates (BPs) or an altered bone quality have been advocated. The aims of the present study were to analyze alveolar mandibular vascularization and bone quality in rats with BRONJ.
MATERIALS AND METHODS: Thirty-eight Sprague-Dawley rats were randomized into two groups: zoledronic acid (ZA), n = 27, and control (CTRL) n = 11. The ZA group received a weekly IV injection of ZA (100 μg/kg) during 10 weeks. The CTRL group received saline. After 6 weeks, extraction of the right mandibular molars was performed. Rats were sacrificed after 14 weeks. Microtomography characterized bone lesions and vascularization after injection of a radio-opaque material. Raman microspectroscopy evaluated bone mineralization.
RESULTS: Fifty-five percent of ZA rats presented bone exposure and signs of BRONJ. None sign was found at the left hemimandible in the ZA group and in the CTRL group. Vascular density appeared significantly increased in the right hemimandibles of the CTRL group compared to the left hemimandibles. Vascularization was reduced in the ZA group. A significantly increased of the mineral-to-amide ratio was found in the alveolar bone of ZA rats by Raman microspectroscopy.
CONCLUSIONS: In a rat model of BRONJ, microtomography evidenced osteonecrosis in BRONJ. Raman spectroscopy showed an increased mineralization. Vascularization after tooth extraction was impaired by ZA. CLINICAL RELEVANCE: Prolonged BP administration caused an increase in the mineralization and a quantitative reduction of the vascularization in the alveolar bone; both factors might be involved concomitantly in the BRONJ pathophysiology.

Entities:  

Keywords:  BRONJ; Bisphosphonate; Microtomography; Osteonecrosis; Raman microspectroscopy; Rat model; Vascularization

Mesh:

Substances:

Year:  2018        PMID: 29453497     DOI: 10.1007/s00784-018-2385-2

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  66 in total

Review 1.  A systematic review of bisphosphonate osteonecrosis (BON) in cancer.

Authors:  Cesar Augusto Migliorati; Sook-Bin Woo; Ian Hewson; Andrei Barasch; Linda S Elting; Fred K L Spijkervet; Michael T Brennan
Journal:  Support Care Cancer       Date:  2010-04-22       Impact factor: 3.603

Review 2.  What is the impact of bisphosphonate therapy upon dental implant survival? A systematic review and meta-analysis.

Authors:  Javier Ata-Ali; Fadi Ata-Ali; David Peñarrocha-Oltra; Pablo Galindo-Moreno
Journal:  Clin Oral Implants Res       Date:  2014-11-19       Impact factor: 5.977

3.  Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment.

Authors:  Tae-Geon Kwon; Chung-O Lee; Jin-Woo Park; So-Young Choi; Girdhari Rijal; Hong-In Shin
Journal:  Clin Oral Implants Res       Date:  2012-12-26       Impact factor: 5.977

4.  Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group.

Authors:  H A Pols; D Felsenberg; D A Hanley; J Stepán; M Muñoz-Torres; T J Wilkin; G Qin-sheng; A M Galich; K Vandormael; A J Yates; B Stych
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

5.  Development of a rat model of bisphosphonate-related osteonecrosis of the jaw (BRONJ).

Authors:  Karen L Marino; Ibrahim Zakhary; Rafik A Abdelsayed; Jared A Carter; Jack C O'Neill; Rania M Khashaba; Mohammed Elsalanty; Mark R Stevens; James L Borke
Journal:  J Oral Implantol       Date:  2011-09-09       Impact factor: 1.779

6.  Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

Authors:  Tony Mavrokokki; Andrew Cheng; Brien Stein; Alastair Goss
Journal:  J Oral Maxillofac Surg       Date:  2007-03       Impact factor: 1.895

7.  Jaw Bone Samples From Bisphosphonate-Treated Patients: A Pilot Cohort Study.

Authors:  Carina Cardemil; Peter Thomsen; Cecilia Larsson Wexell
Journal:  Clin Implant Dent Relat Res       Date:  2015-04-27       Impact factor: 3.932

8.  Prevention of osteonecrosis of the jaw by mucoperiosteal coverage in a rat model.

Authors:  J Abtahi; F Agholme; P Aspenberg
Journal:  Int J Oral Maxillofac Surg       Date:  2013-03-15       Impact factor: 2.789

9.  Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis.

Authors:  J T Harrington; L-G Ste-Marie; M L Brandi; R Civitelli; P Fardellone; A Grauer; I Barton; S Boonen
Journal:  Calcif Tissue Int       Date:  2003-12-05       Impact factor: 4.333

10.  Bisphosphonate related osteonecrosis of the jaw: A minipig large animal model.

Authors:  Christoph Pautke; Kilian Kreutzer; Jochen Weitz; Martina Knödler; Daniela Münzel; Gabriele Wexel; Sven Otto; Alexander Hapfelmeier; Stephen Stürzenbaum; Thomas Tischer
Journal:  Bone       Date:  2012-05-07       Impact factor: 4.398

View more
  7 in total

1.  In vivo quantification of mandibular bone remodeling and vascular changes in a Wistar rat model: A novel HR-MRI and micro-CT fusion technique.

Authors:  Dandan Song; Sohaib Shujaat; Ruiting Zhao; Yan Huang; Eman Shaheen; Jeroen Van Dessel; Kaan Orhan; Greetje Vande Velde; Ruxandra Coropciuc; Ruben Pauwels; Constantinus Politis; Reinhilde Jacobs
Journal:  Imaging Sci Dent       Date:  2020-09-16

2.  In vitro and in vivo studies using non-traditional bisphosphonates.

Authors:  Lilian I Plotkin; Sonja Buvinic; Julián Balanta-Melo
Journal:  Bone       Date:  2020-02-26       Impact factor: 4.398

3.  Small Extracellular Vesicles Derived from Adipose Tissue Prevent Bisphosphonate-Related Osteonecrosis of the Jaw by Promoting Angiogenesis.

Authors:  Jiao Huang; Lin Wang; Weidong Tian
Journal:  Int J Nanomedicine       Date:  2021-05-07

Review 4.  Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  J I Aguirre; E J Castillo; D B Kimmel
Journal:  Bone       Date:  2021-09-11       Impact factor: 4.398

5.  Extensive protein expression changes induced by pamidronate in RAW 264.7 cells as determined by IP-HPLC.

Authors:  Sang Shin Lee; Soung Min Kim; Yeon Sook Kim; Suk Keun Lee
Journal:  PeerJ       Date:  2020-05-21       Impact factor: 2.984

Review 6.  From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights.

Authors:  Alexandre Anesi; Luigi Generali; Laura Sandoni; Samantha Pozzi; Alexis Grande
Journal:  Int J Mol Sci       Date:  2019-10-04       Impact factor: 5.923

7.  PCA-Assisted Raman Analysis of Osteonecrotic Human Femoral Heads.

Authors:  Eiji Ishimura; Wenliang Zhu; Elia Marin; Taigi Honma; Nobuhiko Sugano; Wataru Ando; Giuseppe Pezzotti
Journal:  Methods Protoc       Date:  2022-01-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.